세계의 인간 배아줄기세포(hESC) 시장

Global Human Embryonic Stem Cell (hESC) Research Market to Reach US$1.4 Billion by 2030

The global market for Human Embryonic Stem Cell (hESC) Research estimated at US$905.5 Million in the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$988.5 Million by the end of the analysis period. Growth in the Stem Cell Biology Research Application segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$241.1 Million While China is Forecast to Grow at 6.0% CAGR

The Human Embryonic Stem Cell (hESC) Research market in the U.S. is estimated at US$241.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$219.3 Million by the year 2030 trailing a CAGR of 6.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 5.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Human Embryonic Stem Cell (hESC) Research Market - Key Trends and Drivers Summarized

Human embryonic stem cells (hESCs) represent a cornerstone of regenerative medicine, offering unprecedented potential in the treatment of a broad spectrum of diseases, from genetic disorders to degenerative conditions. Discovered over two decades ago, these cells are pluripotent, capable of differentiating into almost any cell type in the human body. This unique ability makes them invaluable for medical applications, though their use raises ethical concerns due to their derivation from human embryos. Advances in the field have shifted from using animal-based components to xeno-free and human-derived materials for cultivating hESCs, enhancing their applicability in clinical settings. This shift includes the development of feeder-free culture systems that allow hESCs to grow in controlled environments using human-sourced materials, which is critical for maintaining the undifferentiated state of these cells while minimizing the risk of contamination.

The process of directing hESCs to differentiate into specific cell types necessary for therapeutic applications involves intricate manipulation of their culturing conditions. This includes the use of specific growth factors, three-dimensional scaffolding, and co-cultures with other cell types to guide their growth into desired lineages, such as neuronal or cardiac cells. However, the differentiation process is fraught with challenges, including inefficiencies in directing cells and the risk of tumorigenicity from residual undifferentiated cells. Moreover, the complex nature of human tissues requires increasingly sophisticated in vitro models to ensure accurate cell development and integration into host tissues. Despite these hurdles, ongoing research and clinical trials continue to demonstrate the vast therapeutic potential of hESCs, addressing a range of conditions with previously limited treatment options, thus highlighting both the scientific promise and the ethical and regulatory complexities associated with their use.

Looking forward, the hESC research field is driven by several key growth factors that enhance both scientific advancement and public acceptance of stem cell therapies. Innovations in three-dimensional culturing technologies have significantly improved the viability of hESCs in research and therapeutic contexts. Automation and advancements in gene-editing technologies, like CRISPR/Cas9, have refined the processes of cell culturing and genetic modification, making treatments more personalized and reducing the risk of immune rejection. Additionally, the transition to synthetic and xeno-free culturing components has aligned stem cell therapies with regulatory standards and increased their safety for clinical use. Public awareness and evolving ethical considerations continue to shape legislative frameworks, facilitating research and broadening the application of hESC therapies in medicine. International collaboration and standardization efforts, coupled with substantial funding from both public and private sectors, are accelerating the pace of research and expanding the therapeutic potential of hESCs across a wide array of medical conditions. These factors collectively foster a dynamic and rapidly advancing field that continues to push the boundaries of medical science and ethical practice.

Select Competitors (Total 24 Featured) -

• Astellas Institute of Regenerative Medicine
• Asterias Biotherapeutics, Inc.
• BD Biosciences
• Cell Cure Neurosciences Ltd.
• Cellular Dynamics International
• GE Healthcare
• PerkinElmer, Inc.
• Reliance Life Sciences Ltd.
• Research & Diagnostics Systems, Inc.
• STEMCELL Technologies, Inc.
• Stemina Biomarker Discovery, Inc.
• Takara Bio, Inc.
• TATAA Biocenter AB
• Thermo Fischer Scientific Inc.
• UK Stem Cell Bank
• ViaCyte, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Human Embryonic Stem Cell (hESC) Research - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Breakthroughs in Regenerative Medicine Expand Addressable Market Opportunity
  • Rising Prevalence of Chronic Diseases Drives Demand for hESC-Based Therapies
  • Advances in Genomic Editing Propel Growth
  • Technological Innovations in Cell Culture Techniques Accelerate Market Growth
  • Integration of AI and Machine Learning in Stem Cell Research Throws the Spotlight on Precision Medicine
  • Rising Investments in Biotechnology Sustain Growth in hESC Research
  • Growing Focus on Personalized Medicine Drives Innovation in hESC Therapies
  • Challenges in Ethical Considerations and Public Perception Impact Market Dynamics
  • Emerging Applications in Drug Discovery and Toxicology Testing Create Growth Opportunities
  • Increasing Use of hESCs in Neurological Disorder Treatments Generates Demand
  • Evolution of 3D Bioprinting Technology Spurs Demand for hESCs in Tissue Engineering
  • Expansion of Biopharmaceutical Industry Boosts Innovation in hESC Research
  • Advances in Cryopreservation Techniques Strengthen Viability of hESCs
  • Novel Applications in Cardiovascular Disease Treatments Propel Growth of hESC Research
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Human Embryonic Stem Cell (hESC) Research Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Stem Cell Biology Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for Stem Cell Biology Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Toxicology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World 7-Year Perspective for Toxicology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 12: USA Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 13: USA 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• CANADA
  • TABLE 14: Canada Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: Canada 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• JAPAN
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 16: Japan Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: Japan 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• CHINA
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 18: China Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 19: China 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• EUROPE
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 20: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 21: Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 22: Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• FRANCE
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 24: France Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: France 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• GERMANY
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 26: Germany Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: Germany 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• ITALY
  • TABLE 28: Italy Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 29: Italy 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• UNITED KINGDOM
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 30: UK Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: UK 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 32: Rest of Europe Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Rest of Europe 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• ASIA-PACIFIC
  • Human Embryonic Stem Cell (hESC) Research Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 34: Asia-Pacific Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: Asia-Pacific 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 36: Rest of World Recent Past, Current & Future Analysis for Human Embryonic Stem Cell (hESC) Research by Application - Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 37: Rest of World 7-Year Perspective for Human Embryonic Stem Cell (hESC) Research by Application - Percentage Breakdown of Value Sales for Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering and Toxicology Testing for the Years 2024 & 2030

IV. COMPETITION